Product NDC: | 55566-8301 |
Proprietary Name: | FIRMAGON |
Non Proprietary Name: | degarelix |
Active Ingredient(s): | 20 mg/mL & nbsp; degarelix |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | POWDER, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55566-8301 |
Labeler Name: | Ferring Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022201 |
Marketing Category: | NDA |
Start Marketing Date: | 20090302 |
Package NDC: | 55566-8301-1 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (55566-8301-1) > 4 mL in 1 VIAL, GLASS (55566-8301-0) |
NDC Code | 55566-8301-1 |
Proprietary Name | FIRMAGON |
Package Description | 1 VIAL, GLASS in 1 CARTON (55566-8301-1) > 4 mL in 1 VIAL, GLASS (55566-8301-0) |
Product NDC | 55566-8301 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | degarelix |
Dosage Form Name | POWDER, METERED |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20090302 |
Marketing Category Name | NDA |
Labeler Name | Ferring Pharmaceuticals Inc. |
Substance Name | DEGARELIX ACETATE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes |